Sam Brusco, Associate Editor09.14.23
Mayo Clinic and GE HealthCare began a strategic healthcare partnership for R&D programs that plan to transform patient and clinician experience in radiology practice and novel therapy delivery.
Dubbed “The Strategic Collaboration for Innovation in Medical Imaging and Theranostics,” the collaboration comprises Mayo Clinic and GE HealthCare scientists, tech developers, clinicians, and other healthcare providers. The two seek to better equip clinicians with tech to precisely diagnose and treat medical conditions, as well as personalize the patient experience.
“We are at a critical time in healthcare – technology is rapidly evolving, and we have a responsibility to drive healthcare capabilities through clinical translation and adoption of advanced technologies,” Matthew Callstrom, MD, Ph.D., chair of Radiology at Mayo Clinic in Rochester, Minn., told the press. “This collaboration brings our research and clinical teams’ expertise and feedback closer to product development and commercialization of innovation, ultimately accelerating the rate of translation of our research to patient care and offering greater opportunity for global impact.”
Specifically, the efforts will focus on four core areas:
“Mayo Clinic is globally acknowledged to be among the best in healthcare and care innovation. By collaborating with their scientists, inventors and healthcare providers, we will accelerate innovation and increase the clinical impact of our technologies beyond what either of our organizations could achieve independently,” said Jan Makela, president and CEO of Imaging, GE HealthCare.
The applications span multiple radiological disciplines: cardiology, oncology, radiation oncology, vascular, neurology, nuclear medicine, and urology. Collaboration activities and research will take place at Mayo Clinic’s campus in Rochester, Minn.
Dubbed “The Strategic Collaboration for Innovation in Medical Imaging and Theranostics,” the collaboration comprises Mayo Clinic and GE HealthCare scientists, tech developers, clinicians, and other healthcare providers. The two seek to better equip clinicians with tech to precisely diagnose and treat medical conditions, as well as personalize the patient experience.
“We are at a critical time in healthcare – technology is rapidly evolving, and we have a responsibility to drive healthcare capabilities through clinical translation and adoption of advanced technologies,” Matthew Callstrom, MD, Ph.D., chair of Radiology at Mayo Clinic in Rochester, Minn., told the press. “This collaboration brings our research and clinical teams’ expertise and feedback closer to product development and commercialization of innovation, ultimately accelerating the rate of translation of our research to patient care and offering greater opportunity for global impact.”
Specifically, the efforts will focus on four core areas:
- Rapid acceleration development/clinical translation of advanced MR technologies and techniques via artificial intelligence (AI)-enabled exams.
- Transforming cancer care via precise imaging and dosimetry of targeted theranostic agents, as well as broader access through more efficient radioisotope production.
- Making diagnostic/interventional ultrasound easier and faster to use/read, advancing automation and quantification to improve access, care consistency, and clinician experience.
- Leveraging multi-modal data, AI, and digital health platforms to streamline clinical operations and support personalized diagnosis and therapy.
“Mayo Clinic is globally acknowledged to be among the best in healthcare and care innovation. By collaborating with their scientists, inventors and healthcare providers, we will accelerate innovation and increase the clinical impact of our technologies beyond what either of our organizations could achieve independently,” said Jan Makela, president and CEO of Imaging, GE HealthCare.
The applications span multiple radiological disciplines: cardiology, oncology, radiation oncology, vascular, neurology, nuclear medicine, and urology. Collaboration activities and research will take place at Mayo Clinic’s campus in Rochester, Minn.